Prelude Capital Management, LLC Eli Lilly & CO Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Prelude Capital Management, LLC holds 4,212 shares of LLY stock, worth $3.35 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

4,212

Previous 4,212 -0.0%

Holding current value

$3.35 Million

Previous $3.73 Million -0.0%

% of portfolio

0.24%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $2.64 Million - $3.28 Million	-3,415 Reduced 44.78%	4,212 $3.73 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1.2 Million - $1.6 Million	2,023 Added 36.1%	7,627 $5.93 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $411,748 - $485,397	-784 Reduced 12.27%	5,604 $3.27 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $408,618 - $563,342	-940 Reduced 12.83%	6,388 $3.43 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.55 Million - $2.08 Million	4,428 Added 152.69%	7,328 $3.44 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $179,233 - $210,501	-577 Reduced 16.59%	2,900 $995,000
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $42,444 - $49,456	-132 Reduced 3.66%	3,477 $1.27 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.06 Million - $1.21 Million	-3,568 Reduced 49.71%	3,609 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.29 Million - $1.51 Million	4,611 Added 179.7%	7,177 $2.33 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $967,157 - $1.2 Million	-4,121 Reduced 61.63%	2,566 $735,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $694,336 - $861,675	3,088 Added 85.8%	6,687 $1.85 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $409,738 - $504,240	-1,849 Reduced 33.94%	3,599 $832,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $983,636 - $1.27 Million	5,448 New	5,448 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $87,538 - $115,834	-671 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $98,113 - $113,486	671 New	671 $99,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $128,234 - $154,329	-940 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $1.26 Million - $1.56 Million	-10,609 Reduced 91.86%	940 $130,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $1.23 Million - $1.53 Million	11,549 New	11,549 $1.52 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $51,849 - $60,521	-468 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $318,457 - $374,848	-2,861 Reduced 85.94%	468 $61,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $352,541 - $394,952	3,329 New	3,329 $385,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Eli Lilly & CO Transaction History